SuMMARy
Thrombosis related to central venous catheters is often underappreciated and misdiagnosed, despite its incidence and impact on patient morbidity and mortality 1 . We refer to two cases of catheter-related internal jugular and superior vena cava (SVC) thrombosis due to splenectomy and antiphospholipid syndrome. The role of cardiovascular ultrasound examination in the diagnosis and therapy of vascular thrombosis in the setting of intensive care unit is also discussed.
CASE HISTORIES
A 36-year-old man sustained multiple injuries after a motor vehicle accident. He required splenectomy for delayed splenic rupture on day five post injury. Five days later the patient become haemodynamically unstable. To assess his haemodynamic status, transoesophogeal echocardiography (TOE) examination was performed and unexpectedly demonstrated dense echogenic material coating the catheter in the SVC, consistent with thrombus. No signs of pulmonary embolism or other cardiovascular lesions were found during TOE examination. In addition, laboratory values for haemoglobin were 95 g/l and platelet count 975×10 9 /l, indicating reactive thrombocytosis. In the second case, a 30-year-old woman was discharged home after uneventful caesarean section. Her past medical history was unremarkable. Thirtyfive days postpartum, she was transferred to our hospital with hypertension and acute azotaemia (blood urea nitrogen 30 mmol/l, creatinine 398 μmol/l). Three days later the patient was transferred to the intensive care unit as a consequence of multiorgan failure. On admission to the intensive care unit laboratory, tests revealed haemoglobin 85 g/l, white blood cells and platelet count 3×10 9 /l and 47×10 9 /l respectively. Activated partial thromboplastin time was prolonged and anti-DNA antibody antiphospholipid antibodies, lupus anticoagulant and ß2-glycoprotein I-dependent anticardiolipin antibody were strongly positive. A high level of ß2-glycoprotein I-dependent anticardiolipin antibody was also demonstrated by enzyme-linked immunosorbent assays and the patient therefore was diagnosed as suffering from primary antiphospholipid antibody syndrome. Four days later the patient's haemodynamic condition deteriorated. For this reason, TOE examination was conducted and showed thrombus formation in the SVC associated with a central line.
In our patients, vascular ultrasound examination was also performed and disclosed findings consistent with internal jugular vein catheter-related thrombosis ( Figure 1A) . In both cases, central venous catheters were removed under TOE monitoring that finally showed fresh, mobile thrombus remnants in the SVC protruding into the right atrium. In the first case, thrombus formation had almost obstructed the SVC and it may have contributed to the patient's haemodynamic disturbance (Figures 1B to 1D ). Anticoagulant prophylaxis switched to full dose therapy with subcutaneous enoxaparin and follow-up TOE examination demonstrated complete resolution of thrombus after 22 days ( Figure 1E ). In the second case, although SVC thrombosis was moderate, the patient's clinical condition was very severe and despite aggressive immunosuppressive therapy, she died three days later.
DISCuSSION
Patients with prothrombotic tendencies are at high risk for deep vein thrombosis. The increased propensity to thromboembolic complications in splenectomised patients is mainly attributed to thrombocytosis and to the accumulation of thrombotic substances 2, 3 , whereas antiphospholipid syndrome is an uncommon disorder in the peripartum period associated with a thrombotic tendency due to upregulation of tissue factor 4, 5 . In our patients, presumably alterations in the procoagulant state due to splenectomy and antiphospholipid antibody syndrome, as well as the presence of the central venous catheter, may all have operated simultaneously and may also have contributed to thrombus formation both in the internal jugular vein and SVC.
Although it is very true that critically ill patients may have contraindications to full anticoagulant therapy, in our first case, coagulation abnormalities and the nature of thrombus resulted in full dose low molecular weight heparin therapy. Indeed, in this case, thrombus had almost obstructed SVC while its protruding part in the right atrium was highly mobile. Anticoagulant therapy led to thrombus resolution in a very short period of time; hence it potentially diminished the likelihood of thrombus dislodgement in the bloodstream. E) Time motion echocardiography shows no sign of SVC thrombosis after 22 days of anticoagulant therapy. T=thrombus, SVC=superior vena cava, RIJV=right internal jugular vein, C=catheter, RA=right atrium.
In conclusion, a high index of suspicion for catheter-related thrombotic episodes should be maintained in patients with a prothrombotic tendency and in these cases thromboses were demonstrated during haemodynamic screening TOE.
